Martinón-Torres, F;
Bosch, X;
Rappuoli, R;
Ladhani, S;
Redondo, E;
Vesikari, T;
García-Sastre, A;
Rivero-Calle, I;
Gómez-Rial, J;
Salas, A;
et al.
Martinón-Torres, F; Bosch, X; Rappuoli, R; Ladhani, S; Redondo, E; Vesikari, T; García-Sastre, A; Rivero-Calle, I; Gómez-Rial, J; Salas, A; Martín, C; Finn, A; Butler, R
(2019)
TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines.
Hum Vaccin Immunother, 15 (10).
pp. 2405-2415.
ISSN 2164-554X
https://doi.org/10.1080/21645515.2019.1609823
SGUL Authors: Ladhani, Shamez Nizarali
Abstract
The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22-23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.
Item Type: |
Article
|
Additional Information: |
© 2019 The Author(s). Published with license by Taylor & Francis Group, LLC.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
Keywords: |
TIPICO, infectious diseases, infectomics, vaccine hesitancy, vaccines, vaccinomics |
SGUL Research Institute / Research Centre: |
Academic Structure > Infection and Immunity Research Institute (INII) |
Journal or Publication Title: |
Hum Vaccin Immunother |
ISSN: |
2164-554X |
Language: |
eng |
Dates: |
Date | Event |
---|
3 June 2019 | Published | 14 February 2019 | Accepted |
|
Publisher License: |
Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0 |
Projects: |
|
PubMed ID: |
31158041 |
![](http://static.pubmed.gov/portal/portal3rc.fcgi/2745237/img/27842) |
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/111095 |
Publisher's version: |
https://doi.org/10.1080/21645515.2019.1609823 |
Statistics
Item downloaded times since 09 Aug 2019.
Actions (login required)
![Edit Item](/style/images/action_view.png) |
Edit Item |